Dr. Reddy’s Laboratories Limited is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics).
SHORT TERM PERSPECTIVE
| Company | Dr. Reddy’s Laboratories Limited |
| Recommendation | BUY at CMP |
| CMP | Rs.3892.85 |
| Stop Loss (SL) | Rs.3670 |
| Target Price | Rs.4150-Rs.4250 |
| Time Horizon | 2-4 Weeks |
Intermediate and long term trend is up in this stock. After a mild correction stock is trying to reverse from 50 day EMA which has acted as a major support in previous days on daily chart, clearly showing buying interest among the participant on every dip. Also formed higher top higher bottom formation which is a bullish pattern in nature. Increasing in volume and positive diversion from oscillator indicate that stock can move higher from current level so one can initiate a buy position at CMP with a stop loss of Rs. 3670 (on closing basis) with target price of Rs. 4150-Rs. 4250. Time frame should be 2-4 weeks.
DISCLOSURE IN PURSUANCE OF SECTION 19 OF SEBI (RA) REGULATION 2014
Elite Wealth Advisors Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Advisors Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as read more
For Daily Share Market Updates, Daily debt market review, Market Research Analysis reports, Weekly Techno-Funda Report, Fundamental Analysis Report, Monthly Recommended stock Picks, Equity Trading Tips, Upcoming IPO/NFO/Bonds/Ncd’s updates & other related information Subscribe our research plan